Nath Bio-Genes (India) Ltd. announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company announced net sales or income from operations of INR 233.171 million compared to INR 263.322 million a year ago. Profit from operations before other income was INR 21.608 million compared to INR 12.148 million a year ago. Profit before tax was INR 7.766 million compared to INR 5.746 million a year ago. Net profit after associates was INR 5.785 million or INR 0.36 per basic and diluted share compared to net profit of INR 5.653 million or INR 0.35 per basic and diluted share a year ago.

For the nine months, the company announced net sales or income from operations of INR 1,338.126 million compared to INR 1,758.652 million a year ago. Profit from operations before other income was INR 233.034 million compared to INR 602.368 million a year ago. Profit before tax was INR 179.719 million compared to INR 569.162 million a year ago. Net profit after associates was INR 177.565 million or INR 11.10 per basic and diluted share compared to INR 569.065 million or INR 35.56 per basic and diluted share a year ago.